Literature DB >> 32560626

Addressing chronic persistent headaches after MTBI as a neuropathic pain state.

Albert Leung1,2.   

Abstract

An increasing number of patients with chronic persistent post-traumatic headache (PPTH) after mild traumatic brain injury (MTBI) are being referred to headache or pain specialists as conventional treatment options for primary headache disorders have not been able to adequately alleviate their debilitating headache symptoms. Evolving clinical and mechanistic evidences support the notation that chronic persistent MTBI related headaches (MTBI-HA) carry the hallmark characteristics of neuropathic pain. Thus, in addition to conventional treatment options applicable to non-traumatic primary headache disorders, other available treatment modalities for neuropathic pain should be considered. In this comprehensive review article, the author reveals the prevalence of MTBI-HA and its clinical manifestation, discusses existing clinical and mechanistic evidence supporting the classification of chronic persistent MTBI-HA as a neuropathic pain state, and explores current available treatment options and future directions of therapeutic research related to MTBI-HA.

Entities:  

Keywords:  Chronic mild TBI related headaches; Chronic persistent post-traumatic brain injury headache; MTBI; MTBI-HA; Mild traumatic brain injury; Neuropathic pain state; PPTH; Persistent post-traumatic headaches

Year:  2020        PMID: 32560626     DOI: 10.1186/s10194-020-01133-2

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  7 in total

1.  Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis.

Authors:  Dong Wang; Shishuang Zhang; Xintong Ge; Zhenyu Yin; Meimei Li; Mengtian Guo; Tianpeng Hu; Zhaoli Han; Xiaodong Kong; Dai Li; Jing Zhao; Lu Wang; Qiang Liu; Fanglian Chen; Ping Lei
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

2.  fMRI findings in MTBI patients with headaches following rTMS.

Authors:  Michael Vaninetti; Mike Lim; Aladdin Khalaf; Valerie Metzger-Smith; Matthew Flowers; Alphonsa Kunnel; Eric Yang; David Song; Lisa Lin; Alice Tsai; Roland Lee; Shahrokh Golshan; Albert Leung
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.996

3.  Characterization of persistent post-traumatic headache and management strategies in adolescents and young adults following mild traumatic brain injury.

Authors:  Simple Futarmal Kothari; Peter Preben Eggertsen; Oana Veronica Frederiksen; Mille Moeller Thastum; Susanne Wulff Svendsen; Astrid Tuborgh; Erhard Trillingsgaard Næss-Schmidt; Charlotte Ulrikka Rask; Andreas Schröder; Helge Kasch; Jørgen Feldbæk Nielsen
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

Review 4.  Unveiling the phantom: What neuroimaging has taught us about phantom limb pain.

Authors:  Jonathan D Browne; Ryan Fraiser; Yi Cai; Dillon Leung; Albert Leung; Michael Vaninetti
Journal:  Brain Behav       Date:  2022-02-26       Impact factor: 2.708

5.  Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury.

Authors:  Håkan Ashina; Haidar Muhsen Al-Khazali; Afrim Iljazi; Sait Ashina; Faisal Mohammad Amin; Henrik Winther Schytz
Journal:  J Headache Pain       Date:  2022-08-08       Impact factor: 8.588

6.  Multidimensional pain phenotypes after Traumatic Brain Injury.

Authors:  Linda E Robayo; Varan Govind; Roberta Vastano; Elizabeth R Felix; Loriann Fleming; Nicholas P Cherup; Eva Widerström-Noga
Journal:  Front Pain Res (Lausanne)       Date:  2022-08-19

7.  Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine.

Authors:  Giorgio Lambru; Silvia Benemei; Anna P Andreou; Michelangelo Luciani; Gianluca Serafini; Antoinette Maassen van den Brink; Paolo Martelletti
Journal:  Pain Ther       Date:  2020-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.